Early bronchiectasis in cystic fibrosis detected by surveillance CT

Naveen Pillarisetti1, Barry Linnane, Sarath Ranganathan

  • 1Department of Respiratory Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.

Respirology (Carlton, Vic.)
|May 12, 2010
PubMed

Insights

Early detection of cystic fibrosis lung disease in infants is possible with newborn screening. Comprehensive annual assessments, including CT scans, identified lung disease and bronchiectasis early, leading to adjusted management strategies.

Area of Science:

  • Pediatric Pulmonology
  • Medical Imaging in Cystic Fibrosis

Background:

  • Cystic fibrosis (CF) lung disease onset is increasingly recognized in infancy.
  • Newborn screening (NBS) facilitates early detection and intervention for CF.
  • Early surveillance is crucial for managing this life-shortening genetic disorder.

Observation:

  • Two children diagnosed with CF underwent annual comprehensive assessments from diagnosis.
  • Assessments included lung function tests, limited-slice high-resolution CT scans, and bronchoalveolar lavage (BAL).

Findings:

  • Early, aggressive surveillance detected significant lung disease and bronchiectasis within the first few years of life.
  • The findings prompted a change in clinical management strategies.
  • High-resolution CT scanning demonstrated clinical utility in preschool-aged children with CF.

Implications:

  • CT scanning plays a vital role in the early detection of pulmonary complications in young children with CF.
  • Proactive surveillance strategies can lead to timely interventions and potentially alter disease progression.
  • This approach underscores the importance of integrating advanced imaging into early CF care protocols.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History